Salicylic Acid
JFDA label: VERRUMAL Solution
Indications
Approved
- Acne Vulgaris — acne
- Callosities — keratosis
- Dandruff — dermatitis
- Dermatitis, Seborrheic — seborrheic dermatitis
- Eye Diseases — eye inflammation
- Inflammation — inflammation
- Pruritus — Pruritus
- Psoriasis — psoriasis
- Skin Diseases — skin disease
- Skin Neoplasms — skin cancer
- Sunburn — sunburn
- Warts — common wart
Off-label
- Acute Coronary Syndrome
- Cardiovascular Diseases
- Headache
- Heavy Metal Poisoning
- Hypercholesterolemia
- Infertility
- Keratosis
- Keratosis, Actinic
- Pharyngitis
- Stroke
- Tension-Type Headache
- Thrombophilia
- Thrombosis
Adverse Reactions
Vascular disorders (1)
Not Known Ecchymosis
Nervous system disorders (3)
Not Known Dizziness · Headache · Somnolence
Hepatobiliary disorders (1)
Not Known Hepatitis
Gastrointestinal disorders (10)
Not Known Abdominal discomfort · Abdominal pain upper · Constipation · Decreased appetite · Diarrhoea · Duodenal ulcer · Dyspepsia · Nausea · Oesophagitis · Vomiting
Skin and subcutaneous tissue disorders (7)
Not Known Dermatitis · Erythema · Erythema multiforme · Pruritus · Rash · Skin exfoliation · Urticaria
Psychiatric disorders (2)
Not Known Confusional state · Hallucination
Ear and labyrinth disorders (3)
Not Known Deafness · Hearing impaired · Tinnitus
Investigations (2)
Not Known Feeling abnormal · Weight increased
General disorders and administration site conditions (8)
Not Known Burning sensation · Dysgeusia · Gastric ulcer · Lethargy · Occult blood positive · Oedema · Pain · Skin papilloma
Respiratory, thoracic and mediastinal disorders (2)
Not Known Asthma · Epistaxis
Dosing
Source: openFDA
Warnings & Precautions
Source: openFDA
Warnings & Precautions
Warnings For external use only. When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Pregnancy & Lactation
Lactation
No information is available on the clinical use of salicylic acid on the skin during breastfeeding.
Chemistry & Properties
| Formula | C7H6O3 |
|---|---|
| Molecular weight | 138.12 g/mol |
| IUPAC name | 2-hydroxybenzoic acid |
| CAS | 69-72-7 |
| PubChem CID | 338 |
| InChIKey | YGSDEFSMJLZEOE-UHFFFAOYSA-N |
| logP | 1.09 (XLogP 2.3) |
| Polar surface area | 57.53 Ų |
| H-bond acceptors / donors | 2 / 2 |
| Drug-likeness (QED) | 0.61 |
| Lipinski violations | 0 |
SMILES
O=C(O)c1ccccc1OBiology & Pharmacokinetics
Pharmacokinetics
| BBB penetrant | No (logBB -1.1) |
|---|
Enzyme interactions
| Enzyme | Role | Detail |
|---|---|---|
| CYP2C8 | Inhibitor | — |
Transporters
BCRP (Inhibitor)BCRP (Inhibitor)BSEP (Inhibitor)BSEP (Inhibitor)MATE1 (Inhibitor)MCT (Inhibitor)MCT1 (Inhibitor)MCT4 (Inhibitor)MRP1 (Inhibitor)MRP2 (Inhibitor)MRP4 (Inhibitor)OAT1 (Inhibitor)OAT2 (Inhibitor)OAT3 (Inhibitor)OAT4 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)OCT1 (Inhibitor)OCT2 (Inhibitor)P-gp (Inhibitor)MATE1 (Substrate)MATE2 (Substrate)MCT1 (Substrate)MDR1 (Substrate)MRP2 (Substrate)OATP1B1 (Substrate)OATP1B3 (Substrate)OATP2B1 (Substrate)P-gp (Substrate)
Registered Products (15)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
|---|---|---|---|---|
| Algesal Baume | Cream 6.540 g, 3.460 g | 40 g tube pack varies | JERASH PHARMACEUTICALS LTD.CO/JORDAN | 1.100 |
| Beprosalic Ointment | Ointment 0.05 %, 2 % | 15 g tube | Reda Jardaneh Drug Store | 1.310 |
| Pyralvex | Solution 1 %, of Rhubarb 5 % | 10 ml | Khoury Drug Store | 2.040 |
| Salibet Ointment | Ointment 0.05 %, 3 % | 30 g tube | شركة مستودع ادوية الايمان | 2.280 |
| Salidex Solution | Solution 20 mg, 1.2 mg | 30 ml | PHILADELPHIA PHAEMACEUTICALS.COMP/JORDAN | 2.400 |
| Algesal Baume | Cream 6.540 g, 3.460 g | 100 g tube pack varies | JERASH PHARMACEUTICALS LTD.CO/JORDAN | 2.600 |
| Emacort Topical Solution | Solution 2 %, 0.12 % | 30 ml | JERASH PHARMACEUTICALS LTD.CO/JORDAN | 2.610 |
| psorianol oint | Ointment 0.1 %, 1 % | 30 g tube | MIDDLE EAST PHARMA&CHEMICAL IND/JORDAN | 2.880 |
| VERRUMAL Solution | Solution 10 %, 0.5 %, 8 g | 13 ml | Reda Jardaneh Drug Store | 3.040 |
| DIPROSALIC Ointment | Ointment 0.5 mg, 30 mg/g | 30 g tube | Adatco Drug Store | 3.250 |
| Salicort Oint | Ointment 3 %, 0.12 % | 30gm | Hayat Pharmaceutical Industries CO.PLC/JORDAN | 3.460 |
| Salidex Ointment | Ointment 3 %, 0.12 % | 30 g tube | PHILADELPHIA PHAEMACEUTICALS.COMP/JORDAN | 3.480 |
| Mobilat-N | Cream 0.2 %, 2 % | 50gm | Salam Drug Store | 3.690 |
| Emacort Ointment | Ointment 3 %, 1.2 mg/g | 30 g tube | JERASH PHARMACEUTICALS LTD.CO/JORDAN | 3.940 |
| Elicasal | Cream 5 % %, 0.1 % | 30 gm | شركة مستودع ادوية الايمان | 5.600 |